ESR2 and neoplasm: As shown, Erb-hcAb-CL4 (Figure 7 and Supplementary Figure S4) and 10_12-CL4 (Figure 8 and Supplementary Figure S5) conjugates were found to be selectively cytotoxic for both tumor cell lines in a dose-dependent manner.